GLPGF - Gilead Against Coronavirus And Other News: The Good Bad And Ugly Of Biopharma
Gilead Tests Potential Ebola Treatment for Coronavirus
Gilead Sciences (GILD) announced that it is currently in the process of evaluating the use of its experimental Ebola candidate, Nuc inhibitor GS-5734, for treating 2019-nCov infection. The company is currently engaged in active discussions with clinicians and researchers in China and the United States.
China has currently put a couple of its cities on lockdown to arrest the spread of coronavirus. However, several cases of the ailment have been reported outside of China, thus sparking fears of a global outbreak. The US National Institute of